8/4/23 16:39  | 8/2/23  | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | Founder, | M.d | 2 | 0.0220 | 0 | 93 | 64 | 238 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/15/23 19:30  | 2/13/23  | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | M.d | 0 | 0.00 | 0 | 655 | 31 | 2,746 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/30/22 19:45  | 9/28/22  | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | CEO | M.d | 1 | 0.0011 | 0 | 750 | 56 | 2,091 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/5/22 21:45  | 12/31/21  | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | M.d | 0 | 0.0010 | 0 | 42 | 3 | 1,341 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/27/21 16:03  | 4/26/21  | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | P | 60 | 5.00 | 0 | 12 | 1 | 1,298 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/10/20 11:50  | 6/9/20  | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | P | 10 | 7.73 | 0 | 1 | 0 | 2,560 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/26/20 16:39  | 5/21/20  | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | P | 10 | 8.09 | 0 | 1 | 0 | 2,559 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/4/20 15:25  | 4/30/20  | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | P | 60 | 6.00 | 0 | 10 | 0 | 2,558 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |